安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Mepolizumab: Uses, Dosage, Side Effects, Warnings - Drugs. com
Mepolizumab is used to treat several eosinophil-related conditions including Hypereosinophilic Syndrome (HES), Eosinophilic Granulomatosis with Polyangiitis (EGPA), severe asthma, and chronic rhinosinusitis with nasal polyps (CRSwNP)
- Discover a COPD Treatment Option | NUCALA (mepolizumab)
NUCALA (mepolizumab) is now approved as an add-on, prescription maintenance treatment for adults with uncontrolled eosinophilic COPD Not for sudden breathing problems
- Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic . . .
Mepolizumab is a humanized monoclonal antibody that targets interleukin-5, a cytokine that plays a central role in eosinophilic inflammation, which is present in 20 to 40% of patients with
- Mepolizumab (subcutaneous route) - Mayo Clinic
Mepolizumab injection is used with other medicines to treat severe asthma It is given to patients whose asthma is not controlled with their current asthma medicines It is also used to treat eosinophilic granulomatosis with polyangiitis (EGPA) and hypereosinophilic syndrome (HES)
- Mepolizumab Injection: MedlinePlus Drug Information
Mepolizumab injection is used along with other medications to prevent wheezing, difficulty breathing, chest tightness, and coughing caused by asthma in certain children 6 years of age and older and adults whose asthma is not controlled with their current asthma medication (s)
- Mepolizumab Injection: Uses Side Effects - Cleveland Clinic
Mepolizumab is a medication that treats severe asthma This condition causes your airways to narrow and swell Mepolizumab can also treat condition that cause a high eosinophil count, which are a type of white blood cell
- label - Food and Drug Administration
NUCALA (mepolizumab) injection, for subcutaneous use • Injection: 100 mg mL, single-dose, prefilled autoinjector or single-dose Initial U S Approval: 2015
- Mepolizumab: Uses, Interactions, Mechanism of Action - DrugBank Online
Mepolizumab is a fully-humanized monoclonal IgG1 kappa anti-IL-5 antibody used in conjunction with other therapies to treat severe asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome
|
|
|